Growth Metrics

Anaptysbio (ANAB) Leases (2019 - 2025)

Historic Leases for Anaptysbio (ANAB) over the last 7 years, with Q3 2025 value amounting to $13.0 million.

  • Anaptysbio's Leases fell 1243.35% to $13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 million, marking a year-over-year decrease of 1243.35%. This contributed to the annual value of $14.4 million for FY2024, which is 1107.33% down from last year.
  • As of Q3 2025, Anaptysbio's Leases stood at $13.0 million, which was down 1243.35% from $13.5 million recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Leases registered a high of $20.3 million during Q2 2021, and its lowest value of $218000.0 during Q1 2021.
  • Moreover, its 5-year median value for Leases was $16.6 million (2023), whereas its average is $15.9 million.
  • As far as peak fluctuations go, Anaptysbio's Leases tumbled by 8202.8% in 2021, and later soared by 868302.75% in 2022.
  • Over the past 5 years, Anaptysbio's Leases (Quarter) stood at $19.6 million in 2021, then dropped by 8.49% to $17.9 million in 2022, then dropped by 9.63% to $16.2 million in 2023, then dropped by 11.07% to $14.4 million in 2024, then fell by 9.66% to $13.0 million in 2025.
  • Its Leases stands at $13.0 million for Q3 2025, versus $13.5 million for Q2 2025 and $13.9 million for Q1 2025.